Clinical Trial Update: Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications [NA]

View source ↗

Summary

This clinical trial update describes strategies for preventing secondary events after PCI and in conjunction with anti-rheumatic medications, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia
• Rheumatic Diseases

Drugs mentioned

• Unspecified anti-rheumatic medications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Myocardial Ischemia, Rheumatic Diseases | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-06-25